Fish oil omega‐3 fatty acids, mainly eicosapentaenoic acid and docosahexaenoic acid, are
used in the management of several diseases in companion animal medicine, many of which …

Thrombosis or thromboembolism are significant concerns in companion animals and can be
associated with cardiac, metabolic, neoplastic disease processes or can be one …

Objectives To systematically examine the evidence for use of a specific protocol (dose,
frequency, route) of selected antithrombotic drugs, in comparisons to no therapy or to other …

Background Low‐dose aspirin is used to prevent thromboembolic complications in dogs, but
some animals are nonresponsive to the antiplatelet effects of aspirin (“aspirin resistance”) …

Most dogs with immune mediated haemolytic anaemia (IMHA) are hypercoagulable, as
measured by thromboelastography (TEG). Thromboelastography-platelet mapping (TEG …

Disorders of hemostasis can be difficult to fully elucidate but can severely affect patient
outcome. The optimal therapy for coagulopathies is also not always clear. Point of care …

Established “low” aspirin dosages inconsistently inhibit platelet function in dogs. Higher
aspirin dosages consistently inhibit platelet function, but are associated with adverse effects …

OBJECTIVE To assess the in vitro and in vivo platelet function of healthy dogs during
administration of a low-dose aspirin regimen. ANIMALS 16 dogs. PROCEDURES Dogs …

Thromboembolism is a significant complication in many commonly encountered diseases,
and can be a devastating sequel to otherwise treatable conditions. Platelets play an …

Background Cyclosporine has been shown to alter platelet plasma membranes and have a
hypercoagulable effect in humans, leading to thromboembolic complications …